The use of semaglutide is associated with a significantly lower number of hospitalizations among patients with cardiovascular disease, according to a large analysis of clinical data reported by Medscape. The effect was observed both for cardiac-related admissions and for overall hospitalization rates during follow-up.
Waymo’s and Tesla’s autonomous taxis are increasingly portrayed as direct competitors, but in reality they represent two radically different visions of autonomous transport. The differences extend beyond self-driving technology itself to scale, cost structures, and who ultimately profits from autonomy.
Danish pharmaceutical company Novo Nordisk does not plan aggressive price cuts with the launch of the oral version of Wegovy. The company views the pill not as a cheaper alternative, but as another premium product in the rapidly growing obesity-drug market.
Chinese authorities have introduced new, more restrictive rules for AI-powered chatbots, requiring companies to limit the emotional influence of AI on users and to block content related to suicide, gambling, and psychological manipulation. The regulations apply, among others, to popular chatbots developed by startups such as Zhipu AI, MiniMax, and Moonshot.